Building chamber-specific cardiac models with iPSCs
Presented by: Dr Steven Broadbent
Building chamber-specific cardiac models with iPSCs
Atrial fibrillation affects more than 33 million people worldwide. Learn how we’re building better chamber-specific human cardiac models with stem cells on our next webinar.
Watch our webinar where our Senior Scientific Support Manager (and iPSC expert) Steven Broadbent discussed the utility of our axoCells™ cardiomyocytes, covering topics such as:
- How we’ve extensively validated our cardiomyocytes against pharmacologic compounds
- The functional data supporting our atrial and ventricular cardiomyocytes (for use in chamber-specific models)
- A look to the future of cardiotoxicity models